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ABSTRACT 
 
NOVEL BIOLOGICAL MATERIALS FOR FOOD AND 
ENVIRONMENTAL APPLICATIONS  
Özgün Candan Onarman Umu 
M.S. in Materials Science and Nanotechnology 
Supervisor: Assist. Prof. Dr. Turgay Tekinay 
July, 2012 
Probiotics are microorganisms that have many health benefits to their host, such 
as promoting normal intestinal microflora, inhibiting the growth of pathogenic 
microorganisms, improving digestion and stimulation of gastrointestinal 
immunity. Probiotic microorganisms include bacteria, fungi and yeast, and they 
are highly desirable to be used as animal feed supplements. For this application, 
Bacillus species are preferred since they are resistant to extreme environmental 
conditions due to their spore-forming capacity in addition to having other 
important probiotic characteristics. In the first chapter of this study, 84 
independent bacterial colonies were obtained from different bovine chyme 
samples and among them 29 were determined as belonging to genus Bacillus. 
These isolates were principally screened for their antimicrobial activity against a 
group of selected bacteria including pathogenic organisms such as Salmonella 
enterica, Klebsiella pneumoniae, Pseudomonas aeruginosa and Staphylococcus 
aureus. 7 strains (STF4, STF8, STF9, STF10, STF15, STF25 and STF26) with 
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highest antimicrobial activity were further tested for other probiotic properties. 
They were resistant to the gastrointestinal conditions and most of the antibiotics 
tested. In addition, they were checked for the presence of plasmids and 
performed cytotoxicity tests. We propose novel Bacillus strains that have 
potential to be used as probiotic organisms.  
TNT is a hazardous nitroaromatic compound that can be found in soil, sediment 
and water due to extensive contamination from military munitions after the 
World War II. It has many negative health effects on almost all of the living 
organisms (e.g. bacteria, fungi, algae, animal and human). So far, bacteria, fungi 
and plants are commonly used for biodegradation process but only a little is 
known about effect of algae on this issue. However, algae can be used as a good 
alternative for bioremediation and biosensor purposes as they do not require 
advance technology and are effective in terms of cost. 5 different microalgae 
strains (STA1, STA2, STA3, STA4 and STA5) were tested in terms of survival 
in different TNT concentration and biodegradation capability of TNT. These 
strains were isolated from water contaminated with TNT obtained from the 
Brass Factory affiliated with Mechanical and Chemical Industry Corporation 
(MKE) located in Kırıkkale, Turkey. Even though these strains did not use TNT 
as carbon source for growth; they utilize it at different degrees for other 
metabolic activities. Moreover, the growth of STA2 strain was not inhibited by 
high TNT concentrations (up to 50 mg/L TNT).   
 
 
Keywords: probiotic bacteria, Bacillus, feed supplement, TNT, microalgae. 
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ÖZET 
GIDA VE ÇEVRE UYGULAMALARI İÇİN YENİ BİYOLOJİK 
MALZEMELER 
Özgün Candan Onarman Umu 
Malzeme Bilimi ve Nanoteknoloji Programı, Yüksek Lisans 
Tez yöneticisi: Assist. Prof. Dr. Turgay Tekinay 
Temmuz, 2012 
Probiyotikler, üzerinde yaşadıkları canlılara normal bağırsak mikroflorasına 
katkı sağlama, patojen mikroorganizmaların büyümelerini engelleme, sindirimi 
geliştirme ve sindirim sistemi bağışıklığını uyarma gibi bir çok yarar sağlayan 
canlılardır. Probiyotik canlılar; bakteri, mantar ve mayayı içerir ve bu canlılar 
hayvan yem katkı maddesi olarak büyük ölçüde talep görür. Bu uygulama için, 
önemli olan probiyotik özellikleri bulundurmaları yanında spor oluşturma 
kapasiteleri sayesinde Bacillus türleri tercih edilir. Bu çalışmanın  ilk 
bölümünde farklı büyükbaş hayvan kimüslerinden 84 bağımsız koloni elde 
edildi ve bunların arasından 29 tanesinin Bacillus cinsine ait olduğu belirlendi. 
Bu izolatların öncelikle, Salmonella enterica, Klebsiella pneumoniae, 
Pseudomonas aeruginosa ve Staphylococcus aureus gibi patojenik bakterileri de 
içeren seçilmiş bir grup bakteriye karşı gösterdikleri antimikrobiyel aktiviteleri 
test edildi. En yüksek antimikrobiyel aktiviteyi gösteren 7 suş (STF4, STF8, 
STF9, STF10, STF15 ve STF26) diğer probiyotik özellikler için test edildi. Bu 
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suşlar sindirim sistemi şartlarına ve test edilen çoğu antibiyotiğe karşı dirençli 
çıktılar. Ayrıca plasmid varlığı test edildi ve sitotoksisite test edildi. Probiyotik 
canlılar olarak kullanılabilecek potansiyeli olan yeni Bacillus suşları ileri 
sürdük.     
TNT zararlı nitroaromatik bir bileşiktir, toprak, sediment ve su özellikle II. 
Dünya Savaşı’ndan sonra askeri cephaneler yüzünden geniş çapta bu bileşikle 
kirlenmiştir. TNT neredeyse bütün canlılarda (bakteri, mantar, alg, hayavan ve 
insan) bir çok sağlık problemine yol açar. Bugüne kadar bu bileşiğin 
temizlenmesinde genel olarak bakteri, mantar ve bitkiler kullanılmıştır ve bu 
konuda algler hakkında çok fazla bilgi bulunmamaktadır. Ancak, algler yüksek 
teknoloji gerektirmediği ve maliyet olarak uygun olduklarından dolayı biyolojik 
temizleme ve biyoalgılayıcı için iyi alternetiflerdir. 5 farklı mikroalg suşu 
(STA1, STA2, STA3, STA4 ve STA5,) farklı TNT konsantrasyonlarında 
yaşayabilirlikleri ve TNT’yi biyolojik olarak parçalayabilme kapasiteleri 
açısından test edilmiştir. Bu suşlar Makina ve Kimya Endüstrisi Kurumu’na 
bağlı Kırıkkale, Türkiye’de bulunan Pirinç Fabrikası’ndan elde edilen TNT’li 
sudan izole edilmişlerdir. Bu algler, TNT’yi büyüme için karbon kaynağı olarak 
olmasa bile başka metabolik faaliyetler için farklı derecelerde kullanmışlardır. 
Üstelik, STA2 alg suşunun büyümesi yüksek TNT konsantrasyonlarında (50 
mg/L TNT’ye kadar)  inhibe edilmemiştir.   
 
 
Anahtar Kelimeler: probiyotik bakteri, Bacillus, yem katkı maddesi, TNT, 
mikroalg.   
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CHAPTER 1  
Screening and Selection of Novel Bacillus Probiotic Strains 
Isolated from Bovine Chyme 
Part of this study was submitted to be published  as “Screening and Selection of Novel Bacillus 
Probiotic Strains with High Antimicrobial Activity Isolated from Bovine Chyme” Ozgun C. O. 
Umu,
 
Diren Han, Pinar Angun, Alper D. Ozkan and Turgay Tekinay. 
1.1. INTRODUCTION 
1.1.1. The History and the Definition of Probiotics 
Probiotic as a word comes from the Greek ‘pro bios’ meaning ‘for life’ (33, 96). 
The history of probiotics began with the history of man; cheese and fermented 
milk were consumed by Greeks and Romans. The consumption of fermented 
products were preferred especially for children and convalescents (33).  
The definition of the probiotic has been changed and enhanced in terms of 
content through the years. Firstly, Lilly and Stillwell (56) described  probiotics 
as “substances secreted by one microorganism which stimulates the growth of 
another”. Later, probiotics have been generally defined as living organisms 
including bacteria and fungi providing benefits to host beyond inherent basic 
nutrition (23, 59, 65, 95). 
Some of the published definitions are listed below (91). 
 Substances produced by microorganisms that promote the growth of 
other microorganisms (56).  
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 Organisms and substances that contribute to intestinal microbial balance 
(72). 
 A live microbial feed supplement that beneficially affects the host animal 
by improving its intestinal microbial balance (32). 
 A viable mono- or mixed-culture of microorganisms that, applied to 
animal or man, beneficially affects the host by improving the properties of the 
indigenous microflora (42).  
 Living microorganisms that, upon ingestion in certain numbers, exert 
health benefits beyond inherent basic nutrition (38). 
 A microbial dietary adjuvant that beneficially affects the host physiology 
by modulating mucosal and systemic immunity, as well as improving nutritional 
and microbial balance in the intestinal tract (90). 
 A preparation of or a product containing viable, defined microorganisms 
in sufficient numbers, that alter the microflora (by implantation or colonization) 
in a compartment of the host and by that exert beneficial health effects in this 
host (96). 
 Live microorganisms that, when administered in adequate amounts, 
confer a health benefit on the host (29). 
Currently, the lactic acid bacteria are the best-known probiotics, especially 
Lactobacillus sp. and Bifidobacterium sp..  However, Escherichia coli, 
Streptococcus sp., Enterococcus sp., Bacteroides sp., Bacillus sp., 
Propionibacterium sp. and various fungi are the other organisms that are used as 
probiotic (75). Moreover, mixtures of more than one bacterial strain can also be 
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used in some probiotic preparations (83). Probiotic-containing products are 
available for human nutrition, as animal feed supplements and also for 
aquaculture (83, 86, 104). 
There are many criteria that influence the efficacy of a potentially useful 
probiotic. These are viability and reproducibility of probiotic on a large scale 
and during use and storage, ability of probiotic to survive in the intestinal 
ecosystem; and beneficial effect of probiotic on the host (33). 
The potential beneﬁts being claimed include improved nutrition and growth and 
prevention of various gastrointestinal disorders (23). Organisms considered as 
potential probiotic must have some characteristics. These are mentioned below 
(91). 
 Probiotics must be alive. The dead cells may also contribute physiologic 
benefits but they should not be called as probiotic. 
 Probiotics are administered. The native beneficial bacteria are not 
probiotics in their native state. 
 Probiotics must provide health benefit confirmed by tests on host. 
 Pharmaceuticals or topical agents are also admitted as probiotic like food 
supplements or oral delivery.   
 The mechanism of action should not be restricted by the definition of 
probiotics. The delivery of substances may also be probiotic activity even 
though the microorganism cannot survive in intestinal tract. 
 The composition of preparation of probiotic must be known. Deposit of a 
probiotic strain into an internationally recognized culture collection is 
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recommended. Moreover, the strain level should be defined for both consumers 
and scientists. 
1.1.2. Probiotics in Animal Feed-As an Alternative to Antibiotics 
The gastrointestinal tract infections and their consequences are still serious and 
difficult to treat clinical problems in both humans and livestock, despite of 
numerous therapeutic improvements, especially in the field of antibiotics (4, 5, 
13, 83). Moreover, intense use of antibiotics has led to a dramatic increase in the 
number of antibiotic-resistant bacteria. 
The antibiotics are not permitted to be used as feed supplement for livestock and 
these factors arose the concern of alternative products by researchers and feed 
companies (13, 93). European Parliament and the Council of the European 
Union encourage the development of alternative products to replace antibiotics 
as feed supplements for growth promotion (81, 93). An effective and safe 
alternative to antibiotic implementation is deliberately feeding probiotics which 
protect the animal from pathogens by improving microbial balance in the 
gastrointestinal tract to exclude potentially harmful bacteria (13, 68, 75, 93). 
Moreover, probiotics eliminate the negative effect of antibiotics which is the 
further delay of recolonization by normal colonic flora (83). 
1.1.3. The Effects of Probiotics on Health 
Probiotics influence health of host organisms by improving normal intestinal 
microbiota, preventing growth of pathogenic microorganisms, controlling 
infections (prevention of many diseases such as inflammatory bowel disease, 
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mastitis and miscarriage), promoting digestion and intake of feed, inducing the 
immune system decreasing lactose intolerance, lowering serum cholesterol, 
reducing diarrheal incidence, acting as antibiotics, suppressing tumors and 
protecting against colon/bladder cancer (50, 59, 83, 95). Therefore, the use of 
probiotics on livestock enhances the growth of animals, improves efficiency of 
feed conversion and decreases the rate of mortality (50, 59). 
1.1.4. Animal Probiotics 
All animals have micro flora in their intestines to be protected from pathogens 
and to regulate digestive system. Although protective flora which establishes 
itself in gut is very stable, it can be influenced by some dietary and 
environmental factors. The most important factors are excessive hygiene, 
antibiotic therapy, pathogens and stressful conditions (59). Therefore, protection 
and restoring is required for gut micro flora, and it is provided by 
supplementation of probiotic bacteria with feed. 
Moreover, in growing animals, the stabilization of the intestinal microflora leads 
to a high performance level and economic benefits by increasing daily weight 
gain and the reduction of both fattening period and feed expenditure. Also, 
medication and the corresponding costs may be reduced by the use of probiotics 
(79). 
Less well known than the Lactobacilli and Bifidobacteria, there are certain 
species of the spore-forming Bacillus genus that are being used as probiotics, 
notably Bacillus clausii, Bacillus subtilis, Bacillus pumilus, Bacillus coagulans 
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(often mislabeled as ‘Lactobacillus sporogenes’) and B. cereus (45, 91). The use 
of B. subtilis is approved for use as a food supplement in at least one European 
country (Italy), but for other species, this is not the case with the exception of B. 
clausii that is licensed as a prophylactic.  
Bacillus sp. is sporulated living microorganisms. Spore form is a natural stable 
form allowing them to survive in harsh environment, protected from extreme 
heat, cold and mechanical strain without any loss in their vital potential. In spore 
form, various cell walls (Figure 1) protect the nucleus from external stresses.  
 
Figure 1. Cross-section of a Bacillus spore (79) 
 
This natural protection enables the Bacillus products to withstand massive 
strains during feed production and storage, such as high temperatures, pressure, 
shear forces or oxidation impacts (61, 64, 79, 100). Therefore, for all types of 
feed Bacillus spores are suitable and Bacillus sp. is advantageous. Moreover, 
their viability is not affected negatively in low pH values in stomachs of 
animals. Fermentation conditions during production of Bacillus products affect 
the quality and stability of spores (79). 
External spore wall 
Internal spore wall 
Cell wall 
Spore cortex 
Membrane of the cytoplasma 
Cytoplasma with nucleus 
structures 
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1.1.5. Mechanism of Probiotics 
Despite the fact that probiotics provide health benefits to their hosts, little is 
known about the molecular mechanisms of the benefits (3) and also much work 
remains to classify the mechanisms of action of particular probiotics against 
particular pathogens. Moreover, probiotics may use different mechanisms to 
inhibit different pathogens as well as combinations of different mechanisms 
which make the system very difficult and complex (43, 83). 
The mechanisms of probiotics can be categorized based on specific effects of the 
bacteria on the microbial milieu, intestinal epithelium, immune response, 
allergic diseases, distant mucosal sites, and cancer (67).  
Antimicrobial effects of probiotics (33, 43, 83, 95); 
 Modification of microflora to suppress pathogens 
 Production of antimicrobial substances  
 Competition with pathogens to prevent their adhesion to the intestine 
(20, 35, 52) 
 Inhibition of epithelial invasion of pathogens 
 Competition for nutrients necessary for pathogen survival  
 Antitoxin effect (11, 12, 77)  
Effect of probiotics on the intestinal epithelium (33, 83);  
 Promotion of tight contact between epithelial cells forming a functional 
barrier 
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 Reduction of the secretory and inflammatory consequences of bacterial 
infection  
 Enhancement of the production of defensive molecules such as mucins 
 Increase in brush border enzyme production 
Immune effects of probiotics (31, 33, 43, 48, 57, 63, 76, 78, 83, 88, 95); 
 Probiotics as vehicles to deliver anti-inflammatory molecules to the 
intestine  
 Enhancement of signaling in host cells to reduce inflammatory response  
 Switching in immune response to reduce allergy  
 Inducing antibody response to reduce infection  
 Reduction the production of inflammatory substances. 
1.1.6. Characteristics of Probiotics 
A potential probiotic strain is expected to have some desired properties in order 
to provide health benefits to its host. The most important properties of probiotics 
are listed below (67) although a potential probiotic strains does not need to 
fulfill all such selection criteria (71). 
 Human origin is desired for safety for human use (37). This criterion is 
important for species depending on health effects. 
 Acid and bile tolerance is important to predict good survival during 
gastrointestinal transit for oral consumption and also to maintain adhesiveness 
and metabolic activity through this tract (37). 
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 Adhesion to mucosal surface is important to improve immune system, 
compete with pathogens, maintain metabolic activity, and prevent pathogens to 
adhere and colonize. The microorganisms of probiotics are tested for their 
ability to colonize on intestinal epithelia to permanently establish in the host 
over time without the need for periodic reintroduction of the bacteria (8, 15, 22). 
 Identification and characterization of strains accurately and 
documentation of safety is important for food, feed and clinical use, there must 
be no invasion and no degradation of intestinal mucus. 
 Good technological properties are desired. Probiotics should be stable 
and active during processing and storage; if viable organisms are required, 
phage resistance, strain stability, cultivable in large scales and oxygen resistance 
are important and they should have no negative effects on product flavor. 
 Activity against pathogenic bacteria is an important criteria, this can be 
by several different mechanisms; directly by producing bacteriocins or 
antibiotics, by a competitive mechanism of adhesion, by competitive nutrition or 
indirectly by modulating the local immune system. (25, 50, 75, 98). 
1.1.7. Safety of Probiotics 
Safety is an important requirement for probiotics. Antibiotic resistance and 
pathogenicity are the main safety concerns of probiotics. The passage of 
antibiotic resistance genes to other pathogenic microorganisms most probably 
by plasmids (5, 45, 73, 97) and pathogenicity (89) may result with serious health 
problems to host .  
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1.1.7.1. Antibiotic gene resistance of probiotics 
Antibiotic resistance may exist among probiotic microorganisms as with any 
bacteria (90). Chromosomal, transposon or plasmid located genes may be 
responsible from the resistance.  When dealing with selection of probiotic 
strains, it is recommended that probiotic bacteria should not harbour 
transmissible resistance genes to other intestinal and/or food borne 
microorganisms. The transmissible antibiotic resistance gene carrier bacteria 
should not be used in foods and animal feeds (105). 
1.1.7.2. Pathogenicity of probiotics   
The microorganisms can be grouped into three in terms of safety. These are 
nonpathogenic microorganisms, opportunistic pathogens, and pathogens. Every 
microorganism that can live and grow in a host can cause an infection under 
certain conditions such as the case of severely immunocompromized hosts. Most 
intestinal microorganisms are not pathogenic to host who is healthy. The normal 
immune of host influence the growth and metabolism of potential pathogens. 
Current probiotics are generally considered as safe. Moreover, non-viable or 
inactivated microbial preparations are rarely give harm to host and they are least 
likely to cause safety concerns(89). 
1.1.8. Development of Novel Probiotics 
High meat quality, high product yield, improvement of growth and health of 
animals can be provided using probiotic supplementary in diet of animals. 
Probiotics are also effective on prevention of viral illnesses, pathogen growth, 
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digestive tract problems, and immune deficiency problems. Therefore, these 
organisms have significance in food industry, farming and for pets.  
Recently, by development of biotechnology, importance of probiotics has taken 
more attention. As a result, number of scientific studies about isolation of new 
probiotic species has increased. Inspired by this, in this part of the thesis, 
isolation and characterization of new probiotic bacteria strains of Bacillus sp. 
from chyme samples of animals is aimed. For animals, probiotics provide many 
health benefits and also economical gains such that they increase daily weight 
gain and reduce of feed expenditure. Moreover, Bacillus sp. has many 
advantages over other probiotic bacteria strains because of its spore formation 
ability. It can easily survive in extreme physical and chemical conditions such as 
the one of gastrointestinal tract and the probiotic production processes such as 
storage. 
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1.2. MATERIALS AND METHODS 
1.2.1. Bacillus Isolation and Growth Conditions 
Microorganisms were isolated from chyme samples of male cattle between 2 
and 4 years of age. The small intestine was removed as a whole and chyme 
samples were collected by squeezing the intestinal contents into sterile tubes. 
Isolation of the microorganisms was performed as described by Lalloo et al. (53) 
with slight modifications. 1 g of chyme fluid from each sample was suspended 
into 3 ml of 0.9% NaCl solution and inoculated into 9 ml of nutrient broth (NB). 
Samples were incubated at 37ºC for 24 h, followed by incubation at 45ºC for 10 
min to initiate spore formation. 50% (v/v) ethanol was added to a volume of 20 
ml and the suspension was incubated at 20ºC for 1 h. Centrifugation was 
performed at 12000 g for 30 sec, the supernatant was decanted and the pellets 
were incubated at 105ºC for 5 min. Dry pellets were resuspended into 20 ml of 
0.9% NaCl solution and serially diluted in ten-fold increments.  
For Bacillus isolation, MYP (Mannitol Egg Yolk Polymyxin) agar which is 
composed of 225 ml melted base (10 g/L peptone from casein, 1 g/L meat 
extract, 10 g/L D-mannitol, 10 g/L NaCl, 0.025 g/L phenol red and 12 g/L agar), 
2.5 ml of 0.1% Polymyxin B Solution and 12.5 ml of 50% Egg-yolk Emulsion 
was used. Polymyxin in this agar inhibits the growth of gram-negative bacteria 
while Bacillus species are differentiated according to their ability to ferment 
mannitol or degrade lecithin. B. subtilis ferment mannitol result in acid 
production and produce yellow colonies while B. cereus is typically mannitol 
negative and result in pink colonies. 150 µl of each dilution was spread onto 
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MYP agar plates. Plates were incubated at 37ºC for 24 h. Single colonies having 
distinct morphologies were observed on MYP agar plates, collected and 
transferred onto Luria-Bertani (LB) agar plates. Cultures were incubated at 
37ºC, 125 rpm and stored at 4ºC to maintain viability. For long-term storage, 
cultures were maintained at -80ºC in 30% glycerol. 
1.2.2. Probiotic Properties of Isolates 
1.2.2.1. Antimicrobial Activity 
Antimicrobial activity assay was adapted from the method described by 
Saravanakumari et al. (94). Overnight incubated cultures of the isolates were 
horizontally streaked onto LB agar and incubated at 37°C for 48 h. After the 
incubation period, the plates were exposed to chloroform vapor for 90 min for 
the inactivation of active cells. The plates were aerated for 20 min to completely 
remove the residual chloroform by vaporization  and the plate covers were 
changed (5). After that, representative bacteria (Table 1) were streaked vertically 
on the horizontally streaked cells and the plates were incubated at 37°C for 24 h. 
The inhibition on the growth line of bacteria (Table 1) was assessed for 
antimicrobial activity of isolates.  
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Table 1. Microorganisms used in this study 
Bacterial species Strains Origin
a
 
Bacillus subtilis RSHM 03013 (ATCC 6633) RSHM 
Staphylococcus aureus RSHM 96090/07035 (ATCC 25923) RSHM 
Escherichia coli                        RSHM 888 RSHM 
Pseudomonas aeruginosa RSHM 03015 (ATCC 29212) RSHM 
Klebsiella pneumoniae RSHM 06017 (ATCC 10031) RSHM 
Salmonella enterica RSHM 4059 (ATCC 13311, NCTC 74) RSHM 
   
a
RSHM, National Type Culture Collection Laboratory, Ankara, Turkey. 
 
 
1.2.2.2. Sporulation Efficiency 
Sporulation efficiencies of the isolates were measured as described by Barbosa 
et al. (5). The isolates were inoculated (0.1% v/v) in Difco Sporulation Medium 
(DSM) and incubated at 125 rpm and 37°C for 24 h. After 24 h, serial dilutions 
were prepared in ten-fold increments and spread onto LB agar before and after 
heat exposure at 80°C for 20 min. The plates were incubated at 37°C overnight 
and colony forming unit (cfu) numbers were determined. Growth before and 
after heat was compared via the cfu numbers obtained to assess the sporulation 
capacities of the isolates. 
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Spore Formation 
For the purpose of testing the tolerance of spores to simulated gastric fluids and 
bile salts, spore formation procedure was performed. Cultures were grown in 50-
ml DSM medium at 37°C, 250 rpm for 1 day and subsequently centrifuged at 
1500 g for 5 min to refresh the medium of spores. Harvested spores were then 
inoculated into DSM medium and incubated at 37°C, 250 rpm for 2 days. After 
the incubation period, spores were centrifuged at 5000 g for 30 min. The spore 
pellets were washed with 20 ml sterile distilled water and suspended again into 
5-ml sterile water.  Spores of each isolate were stored at 4°C for further use. 
1.2.2.3. Resistance to Simulated Gastric Fluids 
Vegetative cells of the isolates were tested for survival capacity in simulated 
gastric fluids. The method was performed as described by Barbosa et al., Hong 
et al. and Patel et al. (5, 46, 73) with slight modifications.  Briefly, overnight 
grown bacteria were inoculated in LB broth (pH=2.0, adjusted with 37% HCl) 
and the cultures were incubated at 37°C, 125 rpm for 30 min. Samples were then 
serially diluted, spread onto Luria-Bertani (LB) agar and incubated at 37°C for 
24 h. Colonies were counted and compared with those of control cultures. 
The tolerance of spores to simulated gastric fluids was also tested as described 
in Barbosa et al., Duc et al., Hong et al. and Patel et al. (5, 23, 46, 73). ~ 10
8 
to 
10
9 
purified spores per ml (48-h spores) were resuspended into 0.85% NaCl 
solution (pH = 2 adjusted with HCl), incubated and spread onto LB agar plates 
as described for vegetative cells. Controls were spores that were resuspended 
into 0.85% NaCl solution only. Cfu counts were carried out and compared with 
16 
 
those of the controls’ to assess the tolerance of spores to simulated gastric fluid 
conditions.  
1.2.2.4. Bile Salt Tolerance 
Bile salt tolerances of vegetative cells were tested as described by Barbosa et al. 
(5). Overnight cultures of isolated bacteria were inoculated into fresh LB 
supplemented with 0.2% bile salts (50% cholic acid sodium salt, 50% 
deoxycholic acid sodium salt; Sigma-Aldrich, USA) and incubated at 37°C, 125 
rpm. Controls, which are bacteria inoculated into fresh LB, were incubated in 
parallel. Aliquots were taken after 3 h of incubation. In order to determine the 
number of cfu, samples were serially diluted and plated onto LB agar plates. Cfu 
counts were done after incubation at 37°C for 24 h. 
Bile salt tolerances of spores were also assayed as described by Barbosa et al. 
(5). Spores were purified as described by Henriques et al. (44) and ~ 10
8 
to 10
9 
purified spores per ml (48-h spores) were resuspended into an isotonic buffer 
(Bott and Wilson salts: 1.24% K2HPO4, 0.76% H2PO4, 0.1% trisodium citrate, 
0.6% [NH4]2SO4, pH=6.7) containing 0.2% bile salts (50% cholic acid sodium 
salt, 50% deoxycholic acid sodium salt; Sigma-Aldrich Co.). The spores were 
incubated at 37°C, 125 rpm. Controls, which are spores resuspended into Bott 
and Wilson salts only, were incubated in parallel. Aliquots were taken at 0, 1, 3h 
and cfu count was done.   
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1.2.2.5. Biofilm Formation  
Biofilm formation abilities of isolates were tested as described by Barbosa et al. 
(5) with slight modifications. Instead of Sterlini-Mandelstam medium, a biofilm 
growth medium consisting of Luria-Bertani (LB) medium supplemented with 
0.15 M ammonium sulfate, 100 mM potassium phosphate, pH=7, 34 mM 
sodium citrate, 1 mM MgSO4 and 0.1% glucose (39) was used in this study. 
Isolates were grown in this biofilm growth medium to exponential phase and 
transferred into 3 ml of the same medium. Cultures were incubated at 37ºC 
without agitation to an optical density of ~0.01 at 600 nm. An uninoculated 
culture tube and a culture tube inoculated with exponential phase cells were 
prepared 10 min before washing to be used as controls. Tubes were rinsed with 
water and stained with a 1% crystal violet solution for 15 min. Excess stain was 
then removed by washing. A ring of staining on the medium suggests that 
bacteria are capable of forming biofilm. 
1.2.2.6. Antibiotic Susceptibility 
Antibiotic resistances of the isolates were tested as described by Chaiyawan et 
al. and Santini et al. (13, 93) with modifications. Ampicillin, kanamycin, 
chloramphenicol, erythromycin, vancomycin, neomycin, ciprofloxacin, 
streptomycin and gentamicin were the antibiotics tested. Serial dilutions of 
antibiotics were prepared in concentrations ranging between 1 µg/ml and 256 
µg/ml. 160 µl of fresh LB broth, 20 µl of appropriate dilutions of antibiotics, 
and 20 µl of overnight grown isolates were added in each well of 96-well 
microtiter plates. Before adding bacteria, overnight cultures were diluted to 10
6 
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cfu/ml in fresh LB broth by means of OD620 measurements. The microtiter plates 
were incubated at 37ºC for 24 hours and the minimum inhibitory concentrations 
of each antibiotic were determined by measuring the growth of isolates at OD620 
and comparing them to control wells which are only bacteria and LB broth, as 
positive and negative controls respectively. 
Plasmid DNA Extraction and Purification 
Isolates were grown overnight at 37°C and 250 rpm in LB broth. 16-18 h grown 
bacteria were centrifuged at 12000 g for 3 min to obtain cell pellets. Plasmid 
DNA was extracted from the pellet of each isolate by using the QIAprep Spin 
Miniprep Kit (QIAGEN). Gel electrophoresis was performed to detect whether 
the isolates carry plasmid DNA or not.  
1.2.3. Effect of Isolates on Intestinal Cells 
1.2.3.1. Adhesion and Invasion  
Adhesion and invasion assays of Bacillus isolates were performed as described 
by Rowan et al. (84, 85) with slight differences. HT-29 cell monolayers were 
grown in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin 
at 37ºC in 5% CO2 environment. Cells were seeded in 24-well plates containing 
approximately 3x10
5
 cells per well and incubated overnight at 37ºC in 5% CO2. 
Before adhesion and invasion assays, HT-29 cell monolayers were washed three 
times with DMEM and inoculated with 1 ml of bacterial cultures that were 
previously washed with DMEM containing 10% FBS. 24-well plates were 
incubated at 37 ºC in 5% CO2 for 2 h. After the incubation period, HT-29 cells 
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were washed with DMEM to remove nonadherent bacteria. For adhesion assay, 
cells with adhered bacteria in 1 ml of DMEM supplemented with 10% FBS were 
incubated for another 2 h at 37ºC in 5% CO2. For the invasion assay, infected 
cells were incubated for 2 h in 1 ml of DMEM containing 10% FBS and 100 µg 
of gentamicin per ml at 37ºC in 5% CO2. Cells were then washed three times 
with DMEM and lysed with 1 ml of 1% (v/v) Triton X-100 for 5 min at 37ºC. 
Samples from lysed cells were serially diluted and spread onto BHI agar plates 
for cfu count. 
1.2.3.2. Cell Cytotoxicity  
Cytotoxic effects of isolates were tested as described by Rowan et al. and Hong 
et al. (46, 84, 85) with modifications. An MTT based in vitro toxicology assay 
kit (MTT; Sigma) was used to measure total cellular metabolic activity, the 
presence of which directly corresponds to the lack of cytotoxic effects. HT-29 
cell monolayers were grown in DMEM supplemented with 10% FBS and 1% 
penicillin-streptomycin at 37ºC in 5% CO2 environment. The cells were then 
transferred to 96 well-plates with approximately 5x10
4
 cells in each well and 
incubated overnight at 37ºC in 5% CO2 atmosphere. Filter sterilized (by 0.2 µm 
pore size membranes) supernatants of overnight grown bacteria (BHI, 37ºC, and 
125 rpm) were added to test plates before and after heat treatment (95ºC, 10 
min). 4 replicates were done for supernatant of each isolate. 1% Triton X-100 
(Sigma) and PBS were used as positive and negative controls, respectively. 
Cells infected with bacterial supernatant were incubated overnight at 37ºC in 5% 
CO2. After the incubation period, media in each well were removed and 100 µl 
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of DMEM supplemented with PBS containing 0.5 % MTT was added to wells. 
Plates were incubated at 37°C for 4 h. 100 µl of MTT solubilization solution 
(Sigma) was also added to wells after 4 h. The absorbance of the wells was 
measured at 570 nm by using microplate reader (SpectraMax M5, Spectra Lab.). 
Background absorbance of well plates was also measured (at 690 nm) and 
subtracted from 570 nm measurements. Toxicities of the supernatants on HT-29 
cells were determined by using the equation (85): 
 
(
                                    
                                       
)      
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1.3. RESULTS AND DISCUSSION 
Use of Bacillus sp. as probiotics is increasing since these species are spore-
formers which make them more effective in surviving in harsh conditions. 
Bacillus species have been used in some commercial probiotic products (21). 
Bactisubtil (B. cereus strain IP5832), Enterogermina (B. clausii), Biosubtyl Nha 
Trang (B. pumilus), Bispan (B. polyfermenticus) and Toyocerin (Bacillus cereus 
var. toyoi) are some examples of commercially available Bacillus probiotics (21, 
23). Moreover, the preparation of natto, a fermented  soybean product 
originating in Japan, involves the use of B. subtilis to facilitate the fermentation 
process, indicating that Bacillus species have been safely used in foodstuff for a 
considerable period of time (46). 
It was reported previously that Bacillus species that have different probiotic 
characteristics were isolated from the GIT of broilers and fish (5). In this study, 
Bacillus strains were isolated from cattle chyme and screened them for probiotic 
potential, including antimicrobial activity. Isolation of novel strains with high 
antimicrobial activity against pathogenic bacteria such as S. aureus, P. 
aeruginosa, S. enterica, K. pneumoniae and other probiotic characteristics from 
bovine chyme is important for the development of probiotic bacteria as feed 
supplements. Moreover, the commercial product Toyocerin (Bacillus cereus 
var. toyoi) which is the first probiotic to receive authorisation in the European 
Union to be used as an additive in animal nutrition and is one of the most 
studied at scientific level was tested in terms of antimicrobial activity and 
resistance to antibiotics and compared with isolates.  
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1.3.1. Bacillus Isolation and Growth Conditions 
For potential Bacillus probiotic isolation, chyme samples of male cattle between 
2 and 4 years of age were used as sources. Samples were collected from the 
chyme of 8 different cattle and 84 independent isolates were obtained. Isolates 
were grown on MYP agar, 29 of them were found to be the members of the 
genus Bacillus. When heat treated and grown in DSM broth, all 29 isolates were 
observed as spore-formers. 
1.3.2. Probiotic Properties of Isolates 
1.3.2.1. Antimicrobial Activity 
Antimicrobial effects of the selected Bacillus isolates and the commercial 
probiotic product Toyocerin (Bacillus cereus var. toyoi) were tested against 
different indicator strains, including both gram-negative and gram-positive 
bacteria (Table 1). Although all isolates showed some antimicrobial activity, 7 
(STF4, STF8, STF9, STF10, STF15, STF25 and STF26) showed strong 
inhibitory activity among the 29 strains and these 7 strains also showed higher 
antimicrobial activity than Toyocerin against some of the indicator strains 
(Table 2). Representative photos of inhibition zones were shown in Figure 2. 
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Table 2. Inhibitory activity of isolates* 
   
Isolates Indicator Strains 
 
 S. aureus P. aeruginosa E. coli B. subtilis K. pneumoniae S. enterica  
STF1 - - - + - - 
 
STF2 - - - - - - 
 
STF3 - - - - - - 
 
STF4 ++ ++ ++ - ++ - 
 
STF5 + ± - ± ± - 
 
STF6 ± ± - + ± ± 
 
STF8 ++ ± + +++ - ± 
 
STF9 + - - ++ - - 
 
STF10 +± ± ± ++ - - 
 
STF11 - - - - ± - 
 
STF12 ± + - ± - ± 
 
STF13 + - - ± +± ± 
 
STF14 + - - - + ± 
 
STF15 +++ ± ± ± - - 
 
STF16 ± - - ± - ± 
 
STF18 ± - - - - ± 
 
STF19 ± - - ± ± ± 
 
STF20 - - + ± ± ± 
 
STF21 ± + - - - - 
 
STF22 ± +± - - ± ± 
 
STF23 - + - + +± - 
 
STF24 - + + - - - 
 
STF25 ± ± + +++ - - 
 
STF26 +++ ± +++ +± ++± ++ 
 
STF27 + - - + - - 
 
STF28 - ± - ± + - 
 
STF29 ± ± - ± - ± 
 
Toyocerin + + + +± + + 
 
 
*The signs reflect the degrees of inhibitory effect on growth from “– ” 
 (no inhibition) to “+++” (increased inhibitory activity by increased inhibition zone). 
 All results were performed in triplicate. 
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Figure 2. A,B,C,D,E,F represent antimicrobial inhibition degrees, ‘-, ±, +, +±, 
++ and +++’ respectively. All antimicrobial results were discussed accordingly. 
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These 7 isolates were therefore chosen for further study. These isolates were 
identified by 16S rRNA sequencing (Figure 3, Table 3) and imaged by SEM to 
analyze their cell morphologies (Figure 4). STF4, STF8, STF15, STF26 were all 
effective in preventing the growth of S. aureus; however, only STF4 showed 
inhibitory effect on P. aeruginosa. In addition, STF8, STF9, STF10 and STF25 
displayed a clear inhibition zone on the growth line of B. subtilis, but only 
STF26 could effectively inhibit the growth of S. enterica. In addition to STF26, 
STF4 also showed strong antimicrobial activity on E. coli and K. pneumoniae 
compared to other isolates. 
                
                   
  
Figure 3. Phylogenetic tree of 7 isolates (STF4, STF8, STF9, STF10, STF15, 
STF25 and STF26) 
Bacillus pumilus strain HPS 1 
Bacillus subtilis strain ISA7 
Bacillus pumilus strain I5 
Paenibacillus  
xylenexedens               
strain B22a 
Paenibacillus sp. B3a  
Bacillus licheniformis 
strain 30AA2-3 
Bacillus subtilis strain LN 
Bacillus subtilis strain ME2 
STF9 
STF4 
STF10 
STF25 
STF15 
STF26 STF8 
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Table 3. Identification of selected isolates 
Isolate 16S rRNA sequence analysis   
  Closest known species 
Maximum 
Identity (%) 
STF4 Paenibacillus xylanexedens 96 
STF8 Bacillus subtilis 96 
STF9 Bacillus subtilis 97 
STF10 Bacillus licheniformis 99 
STF15 Bacillus pumilus 97 
STF25 Bacillus licheniformis 99 
STF26 Bacillus pumilus 95 
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Figure 4. SEM images of isolates. (a), (b), (c), (d), (e), (f) and (g) represent 
STF4 (Paenibacillus xylanexedens), STF8 (Bacillus subtilis), STF9 (Bacillus 
subtilis), STF10 (Bacillus licheniformis), STF15 (Bacillus pumilus), STF25 
(Bacillus licheniformis) and STF26 (Bacillus pumilus) respectively. 
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1.3.2.2. Sporulation Efficiency 
Sporulation efficiencies of the isolates STF4, STF8, STF9, STF10, STF15, 
STF25 and STF26 were tested by inducing spore formation in a sporulation 
medium and counting colony numbers before and after heat exposure (80°C). 
Colony numbers were compared and survival percentages were subsequently 
calculated. The results were designated as percentages in Table 4. All isolates 
were spore-formers although their sporulation efficiencies were different. 
1.3.2.3. Resistance to Simulated Gastric Fluids 
Vegetative cells of the isolates STF4, STF8, STF9, STF10, STF15, STF25 and 
STF26 were tested for survival in simulated gastric fluids. All of the tested 
isolates were resistant to simulated gastric fluid conditions although their 
survival rates were different (Table 4). 
Tolerance of purified spores of STF4, STF8, STF9, STF10, STF15, STF25 and 
STF26 to low pH condition of gastric fluids was tested after 30 min and 1 h of 
incubation. After 30 min, there was no reduction in the number of spores 
compared to controls. After 1 h incubation, there were 2-log reduction in STF15 
and STF25 and no difference in STF4, STF8, STF9, STF10 and STF26 spores 
compared to controls. 
1.3.2.4. Bile Salt Tolerance 
Isolates were analyzed for their resistance to intestinal conditions by testing 
survival of both vegetative cells and spores in bile salts medium. When 
vegetative cells were exposed to bile salts, all isolates survived (Table 4). 
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When spores of the isolates were exposed to bile salts, at 0 and 1 h, no reduction 
was observed in the number of spores. After 3 h incubation in LB supplemented 
with bile salts, 2-log reduction was observed in STF25; 1-log in STF4, STF8, 
STF9 and STF10; slight reduction in STF26, and no reduction was noted in 
STF15. 
1.3.2.5. Biofilm Formation 
Biofilm production is desired for prospective probiotics, since it allows the 
probiotic to remain longer in the GIT (46). Biofilm formation provides 
protection for probiotic bacteria against the harsh conditions of the GIT, 
supports spore formation and prevents pathogenic bacteria to hold on to the GIT 
surface (5).  
When grown in LB broth, some isolates namely STF9, STF10, STF15 and 
STF26 formed highly viscous structures on the bottom of the tubes. After the 
biofilm assay these isolates formed a notable ring of crystal violet and these 
rings suggest that the isolates have capacity to form biofilms (Table 4). 
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Table 4. Identification and characterization of selected isolates 
Isolate 
Sporulation 
efficiency 
%
a
 
 Survival 
in bile 
salt
b
 
Survival in 
simulated 
gastric 
fluid
b
 
 
Biofilm 
Formation
c
 
 
  
Vegetative 
form   
Vegetative 
form 
  
Paenibacillus xylanexedens STF4 79.9 + + - 
Bacillus subtilis STF8 127.02 +++ ++++ - 
Bacillus subtilis STF9 22.75 +++ +++ + 
Bacillus licheniformis STF10 173.91 +++ ++ + 
Bacillus pumilus STF15 15.28 + +++++ + 
Bacillus licheniformis STF25 35.2 + ++++ - 
Bacillus pumilus STF26 36.7 ++ ++++ + 
  
 
 
 
a
Sporulation efficiency is given as the percentage of the survivors.  
b
Plus signs 
reflect the degrees of survival in simulated gastric fluid,  “+” denoting the lowest 
survival and  “+++++” the highest. c“+” reflect presence of biofilm formation 
while “-” reflect absence of biofilm formation. All tests were performed in 
triplicate. 
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1.3.2.6. Antibiotic Susceptibility and Plasmid Presence 
Antibiotic susceptibility is considered as one of the most important 
characteristics of probiotic bacteria since the resistance genes could be 
transferred to pathogenic bacteria in the intestinal tract and also passed onto 
humans through the food chain (5, 45, 73, 97). This transfer mostly occurs by 
plasmid-borne resistance genes (97). 
Antibiotic selection and determination of resistance or sensitivity of isolates 
against chosen antibiotics were performed according to the microbiological 
breakpoints used by SCAN (Scientific Committee on Animal Nutrition) (Table 
5) (105). Minimum inhibitory concentration (MIC) values were displayed in 
Table 6. Of the isolates tested, all except STF4 were resistant to ampicillin, 
vancomycin and gentamicin; 4 isolates (STF8, STF9, STF15, and STF25) were 
resistant to kanamycin while another 4 (STF9, STF15, STF25, and STF26) were 
resistant to chloramphenicol. STF4 and STF8 were sensitive to erythromycin 
whereas other isolates displayed resistance to this antibiotic. MIC values of 
STF4 and STF26 against neomycin were lower than the breakpoints mentioned 
in SCAN report; therefore, they were considered as sensitive to neomycin. 3 
cultures (STF15, STF25, and STF26) showed resistance to ciprofloxacin and 
only STF26 exhibited low MIC values to streptomycin. Moreover, Toyocerin 
also showed resistance to most of the antibiotics (ampicillin, chloramphenicol, 
erythromycin, vancomycin, ciprofloxacin and streptomycin). 
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Table 5. The Microbiological Breakpoints Used by SCAN Categorizing 
Bacterial Species as Resistant 
Antibiotic Enterococcus 
faecium 
Pediococcus Lactobacillus Bacillus 
Ampicillin 8 3 2* 2* 
Streptomycin 1024 32 16 64 
Kanamycin/neomycin 1024 32 32 64 
Entamycin 500 4 1 8 
Chloramphenicol 16 16 16 16 
Tetracycline   16   16   16   16 
Erythromycin 4 4 4 4 
Quinupristin/dalfopristin 4 4 4 4 
Vancomycin 4 R 4* 4 
Trimethoprim 8 16 32 8 
Cipro/enrofloxacin 4 16 4* 1 
Linezolid 4 4 4 4 
Rifampin 4 8 32 324 
     
R = resistant 
* = certain species inherently resistant 
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Table 6. Minimum inhibitory concentrations (MIC) for isolates 
Isolates Minimum Inhibitory Concentration (MIC) µg/ml 
 
A K CH E V N CIP S G 
STF4  <1 <1 <1 <1 <1 4 <1 64 <1 
STF8 16 64 8 2 4 64 <1 >128 16 
STF9  64 64 64 8 4 64 <1 128 8 
STF10 128 <1 8 4 8 64 <1 128 16 
STF15 16 64 64 16 4 64 8 >128 8 
STF25 128 64 64 128 128 128 16 128 16 
STF26  32 16 32 32 32 32 4 32 16 
Toyocerin 2 32 128 16 16 8 8 64 4 
         
 A, K, CH, E, V, N, CIP, S and G refer to Ampicillin, Kanamycin, 
Choloramphenicol, Erytromycin, Vancomycin, Neomycin, Ciprofloxacin, 
Streptomycin and Gentamycin respectively. All experiments were performed 
triplicate. 
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After the observation of that most of the isolates display resistance to antibiotics, 
plasmid isolation and visualization was performed to determine whether this 
resistance is due to plasmid-borne resistance genes. If such genes are not 
integrated into the genomic DNA and are instead carried on plasmids, they may 
be transferred to other bacteria in the environment and confer them resistances 
to the same antibiotic. This constitutes a potential health hazard if the recipient 
bacteria are pathogenic, and the absence of plasmid DNA should therefore be 
confirmed for an antibiotic-resistant strain to be recommended as a prospective 
probiotic. For this purpose, plasmid extraction and gel electrophoresis were 
performed. No plasmid presence was detected in the isolates STF4, STF8, STF9, 
STF10, STF15 and STF26; only the sample from STF25 displayed a band after 
gel electrophoresis (Figure 5). Our results suggest that all the samples tested, 
with the possible exception of STF25, carry potential antibiotic resistance genes 
in their genomic DNA and bear no risk of transferring them to other pathogenic 
or non-pathogenic bacteria that may be present in the environment (46).  
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Figure 5. Agarose gel electrophoresis image of plasmid profile of isolates. A, B, 
C, D, E, F and G represent STF4 (Paenibacillus xylanexedens), STF8 (Bacillus 
subtilis), STF9 (Bacillus subtilis), STF10 (Bacillus licheniformis), STF15 
(Bacillus pumilus), STF25 (Bacillus licheniformis) and STF26 (Bacillus 
pumilus) respectively. 
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1.3.3. Effect of Isolates on Intestinal Cells 
1.3.3.1. Adhesion and Invasion  
The ability to adhere to and colonize in the GIT is an important requirement for 
potential probiotics, as the capacity to adhere increases the mean time of 
bacteria in the GIT and allows greater periods of probiotic activity after oral 
introduction of the probiotic strain (47, 87). Therefore, probiotic strains 
displaying stronger adhesion to the GIT are considered to better modify the 
normal intestinal microbiota, prevent the growth of pathogenic bacteria by 
competitive exclusion and induce immune system compared to the non-adherent 
ones (73, 87). HT-29 cell line is used as a model for the testing of adhesion of 
probiotic bacteria, as these cells differentiate into enterocytes (73, 87). Thus, we 
used HT-29 colon carcinoma cell line for the assessment of adhesion.  
Recent research suggests that members of Bacillus species might induce 
important systemic diseases such as septicemia, peritonitis, endocarditis, liver 
failure and meningitis (85). Therefore, invasion studies were conducted for our 
candidate probiotics. 
Abilities of Bacillus isolates to adhere to HT-29 cells were tested. We observed 
that all isolates adhered to the HT-29 cells (Table 7). STF9 could not grow in 
BHI broth; therefore, we could not perform the test for this isolate. STF4 
showed the strongest adherence with a percentage of 2.5% while STF15 showed 
the lowest with 0.002%. Invasion properties of Bacillus isolates were also 
assayed as mentioned above. Assay results demonstrate that none of the bacteria 
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were capable of invading HT-29 cells, with the possible exception of STF9, 
which failed to grow in the assay medium (Table 7). 
1.3.3.2. Cell Cytotoxicity  
MTT assay was used for detection of toxic materials in the supernatants of 
bacteria. This assay was chosen as it has been determined to be more reliable 
and sensitive than others (28). In contrast to previous methods which were based 
on visual evaluation of toxin induced cell damage, the use of MTT has the 
advantage of removing the subjective visual assessment from the assay.  MTT is 
a yellow, water soluble tetrazolium salt which is cleaved in the mitochondria of 
metabolically active cells. In the presence of living cells, MTT solution displays 
a color change as the insoluble purple formazan is formed due to 
intramitochondrial metabolization of MTT (6, 28, 30, 85).  MTT-based assay is 
highly sensitive and suitable for assessing cell viability and cytotoxicity, since 
only living cells produce formazan reaction products (6, 30, 85). 
The cell cytotoxicities of the supernatants of 18 h grown isolates in BHI were 
assayed by using the MTT test. STF9 could not grow in BHI broth; therefore, 
we could not perform the test for this isolate. STF8 and STF15 had heat-stable 
toxic materials in their cell free supernatants; however, the amounts of these 
materials were different. Also, STF4, STF25 and STF26 contained low amounts 
of heat-stable toxic materials in their cell-free supernatants. However, heat 
treatment of the culture supernatants (STF4, STF25 and STF26) eliminated 
toxicity in HT-29, which suggests that toxic materials are protein-based. 
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Moreover, STF10 supernatant showed no toxicity to HT-29 cell line, but when it 
was heated, the test result showed the presence of low toxic material (Table 7).  
 
 
Table 7. Adhesion, Invasion and Cytotoxic Abilities* of Bacillus Isolates for HT-29 
Isolate Bacterial Species 
Adhesion 
(%) 
Invasion 
(%) 
Cytotoxicity (%) 
        Normal Heat treated 
STF4 Paenibacillus xylanexedens 2,500 0 2,9 0 
STF8 Bacillus subtilis 0,010 0 95,2 68,6 
STF9** Bacillus subtilis - - - - 
STF10 Bacillus licheniformis 0,010 0 0 3,8 
STF15 Bacillus pumilus 0,002 0 11,6 7,5 
STF25 Bacillus licheniformis 0,100 0 7,8 0 
STF26 Bacillus pumilus 0,008 0 8,5 0 
      * All results are given as the percentage of the survivors. ** "-" sign indicates that no  
growth on BHI was observed. All tests were performed triplicate. 
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1.4. CONCLUSION 
The aim of this chapter of study was to screen many Bacillus sp. from the GIT 
of bovine in terms of their probiotic properties and select the most effective 
Bacillus probiotic to be used as animal feed supplement. For this purpose, 
different strains were isolated from chyme samples of bovines and probiotic 
characterization tests were applied. As a result, among the isolates, STF4, 
STF10, STF15 and STF26 appeared to have the highest potential as probiotic 
candidates compared to others by considering their antimicrobial effects, 
resistance to simulated gastrointestinal conditions, antibiotic susceptibility, 
colonization capacity and lack of toxicity. Moreover, regarding antimicrobial 
activity, the selected strains are more effective against some of the indicator 
strain than the commercial product Toyocerin. 
  
40 
 
1.5. FUTURE PROSPECTS  
The growth conditions of the selected strains can be optimized to increase 
biomass because these strains are characterized for use as probiotic product. 
Therefore, maximum biomass production is necessary to decrease the cost. In 
fact, the growth conditions (temperature, pH, carbon source, nitrogen source and 
some salts percentages) of one of the strains which is Bacillus pumilus STF26 
was optimized in another study.  
Moreover, the selected potential probiotic bacteria were tested for most of the 
properties of a probiotic. However, for further use of these bacteria as probiotic 
products some additional research is necessary. These future studies that needs 
to be done include in vivo animal experiments and investigation of technical 
properties such as strain stability, bacteriophage resistance and shelf life.  
Finally, animal digestive system conditions are similar to human; therefore, the 
selected potential probiotic Bacillus sp. may also be used as human probiotics. 
For human use purpose, further studies like clinical tests are required.  
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CHAPTER 2 
2,4,6-trinitrotoluene (TNT) biodegradation and survival 
capability of microalgea isolated from TNT-contaminated water  
 
2.1. INTRODUCTION 
2.1.1. Microalgae 
Microalgae are a diverse group of prokaryotic and eukaryotic photosynthetic 
microorganisms that grow rapidly due to their simple structure (55). They can be 
found in most of the terrestrial and aquatic habitat such as oceans, fresh water, 
even on bare rock and soil. 
Algal biomass can be used for food, animal feed, biofertilizer, soil conditioner, 
as feed in aquaculture, biological purification of waste water, production of a 
variety of compounds such as polysaccharides, lipids, proteins, carotenoids, 
pigments, vitamins, sterols, enzymes, antibiotics, pharmaceuticals, and other 
chemicals such as hydrogen, hydrocarbon, biofuel (7). 
Microalgae are the principal primary producers of aquatic ecosystems (60); 
therefore, the tolerance of them to contaminated environments depends. The 
tolerance of microalgae to stressed environments is important because of their 
ecological value. However, knowledge about the mechanisms allowing algal 
adaptation to such extreme conditions is little and more research is necessary on 
this issue for future (60). Algae can be an appealing alternative technology as 
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phytosensors and phytoremediation systems for controlling TNT pollution. 
Plants and algae may be photosensors producing a phenotyping response to 
specific environmental stimuli although in phytoremediation generally plants are 
used for in situ treatment of contaminated sites polluted by a variety of 
hazardous chemicals (9, 18, 74). The plants and algae that are genetically 
engineered may be more appropriate for biosensor applications than hand--held 
biosensors or microbes in many conditions. Moreover, they do not involve 
advance technology and are cost effective (74). 
2.1.2. 2,4,6-trinitrotoluene (TNT) 
2,4,6-Trinitrotoluene (TNT) is a highly explosive, single-ring nitroaromatic 
compound that is a crystalline solid at room temperature (19). It is formed by 
nitration of toluene with three sequential reactions (Figure 6). The products of 
these reactions are mono-, di- and lastly trinitrotoluene respectively. 
 
Figure 6. Formation of TNT from toluene (69). 
43 
 
 
TNT is spread into soil and water systems mainly due to its use of high amounts 
during the two World Wars (17); furthermore, it has been used as dyes, 
pesticides and explosives historically. As a result, the soil, sediment and water 
were contaminated extensively with this toxic explosive by production, use and 
disposal of it (10, 14, 27). Figure 7 shows the image of pink water which is the 
waste stream generated during the process of loading, assembling, packaging, 
and demilitarization of munitions by army ammunition plants (AAPs) typically 
contains 2,4,6-trinitrotoluene (TNT) with photochemical activity that imparts the 
pink color (49, 66, 92).  
 
 
Figure 7. Image of Pink Water 
 
In surface water, 2,4,6-trinitrotoluene can be rapidly broken down into other 
chemical compounds by sunlight with photochemical activity (103). However, it 
accumulates in groundwater and sediments, and breaking down of TNT is more 
slowly by microorganisms in these sites. 
2,4,6-trinitrotouluene (TNT) is the most dangerous one of the nitroaromatic 
compounds having mutagenic properties, persistency and contaminated sites 
44 
 
with large area (14). It is indicated by previous research that gram-positive 
bacteria, fungi, actinomycetes, yeast and fresh-water algae as well as plant 
growth are inhibited by TNT at concentrations between 2 and 50 mg/L (34, 51, 
99, 106). Moreover, TNT presents significant risks of toxicity, mutagenicity and 
carcinogenicity to animals (62), especially mammals such as human. It causes 
many negative health effects on human including anemia, abnormal liver 
function, skin irritation, and cataract development. Animals that have been 
exposed to TNT have been observed to develop similar blood and liver effects, 
as well as spleen enlargement and other harmful effects on the immune system 
(41). 
The health standards of TNT on human that are determined by some federal and 
state bodies are as following (102); 
 The Occupational Safety and Health Administration (OSHA) set a general 
industry permissible exposure limit (PEL) of 1.5 milligrams per cubic meter 
(mg/m
3
) of workplace air for an 8-hour workday for a 40-hour work week. 
 The National Institute for Occupational Safety and Health (NIOSH) 
recommended exposure limit (REL) for TNT during an 8-hour workday, 40-
hour work week is 0.5 mg/m
3
. 
 The American Conference of Governmental Industrial Hygienists (ACGIH) 
has set a threshold limit value (TLV) of 0.1 mg/m
3
. 
2.1.2.1. Remediation Methods of TNT 
For remediation of TNT, there are traditional methods which are conducted ex-
situ and biological-based methods conducted in-situ. The traditional remediation 
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methods are incineration, landfilling, thermal desorption, and soil washing (1). 
The recent ex-situ methods include soil slurry reactors, landfarming and soil 
composting and all are based on microbial community that is to treat 
contaminated media (1, 16). These recent techniques have high expenses and 
some processes used are hazardous to ecosystem of environment. Therefore, ex-
situ treatment of TNT may not be appropriate for large-scale contaminated sites 
in terms of economy. The in-situ methods include natural attenuation, 
biostimulation, bioaugmentation, and phytoremediation (1) and they have many 
advantages over ex-situ methods (54, 80). The cost and energy consumption is 
lower, remediation is more environmental friendly, process is easier as the 
processes such as soil excavation, transportation and mixing are eliminated. 
Ecosystem of environment is not damaged and it is commonly accepted by 
public. 
 Natural attenuation is based on the activity of the indigenous microbial 
community on the contaminant-of-interest taking long time as can be 
decades. 
 Biostimulation method is the stimulation of indigenious microorganisms to 
improve the activity by adjusting soil conditions such as nutrient content, 
pH, and redox potential. 
 Bioaugmentation is the addition of specific microorganism that have been 
tested in laboratory for its degradation ability. 
 Phytoremediation is the growth of plants on contaminated sites, the ability of 
plants which is growing on various soil and climate types is an advantage for 
remediation processes. 
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2.1.3. Objective 
TNT is a very toxic chemical and its contamination is widespread in soil, 
sediment and water systems especially after the two World Wars. It has many 
negative health effects to almost all living organisms including bacteria, fungi, 
actinomycetes, yeasts, algae, animals and human. In previous research, for TNT 
bioremediation generally bacteria, fungi and plants are used. A little is known 
about algal adaptation and its mechanism. However, algae can be used as an 
attractive alternative for bioremedition and biosensor purposes as they do not 
require advance technology and are effective in terms of cost. Originated from 
this, in the second part of the thesis algae isolated from water contaminated with 
TNT are tested in terms of survival in different TNT concentration and 
biodegradation capability of TNT.   
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2.2. MATERIAL AND METHODS 
2.2.1. Algae and culture conditions 
The microalgae were grown in TAP medium (Table 8) (2, 36, 40, 101) for 6 
days under light before inoculations.  All incubations with TNT were carried out 
in dark. The inoculation percentage was 1 %, 400 μL of algae culture were 
inoculated into 40 ml medium in 100 ml-flask as recommended volume rate 
(70). The incubation temperature was 23°C and shaked at 170 rpm. 
The mediums with TNT were prepared as TAP medium but instead of NH4Cl 
which is the nitrogen source, TNT was used. The other components were taken 
as constant given in Table 8. TNT stock solution concentration of which is 100 
mg TNT/L was used as TNT source. 
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Table 8. TAP medium components 
Stock Solution 
(SL) 
Volume Component Concentration 
in SL 
Conc. In final 
medium 
Tris base 2.42 g H2NC(CH2OH)3 
Tris(hydroxymeth
yl)-aminomethan 
     2.00·10-2 M 
 
TAP-salts  
(Beijerinck 
salts) 
 
25 ml 
 
NH4Cl 
MgSO4·7H2O 
CaCl2·2H2O 
 
15 g · L-1 
4 g · L-1 
2 g · L-1 
 
7.00 · 10-3 M 
8.30 · 10-4 M 
4.50 · 10-4 M 
 
Phosphate 
solution 
 
1 ml 
 
K2HPO4 
 
28.8 g · 100 ml-1 
 
1.65 · 10-3 M 
 
 
Trace elements 
solution (Hutner 
trace elements) 
 
 
 
 
 
 
Acetic acid, 
conc. 
 
 
1ml 
 
 
 
 
 
 
 
 
1ml 
KH2PO4 
 
Na2EDTA · 2H2O 
ZnSO4 · 7H2O 
H3BO3 
MnCl2 · 4H2O 
FeSO4 · 7H2O 
CoCl2 · 6H2O 
CuSO4 · 5H2O 
(NH4)6MoO3 
 
CH3COOH 
14.4 g · 100 ml-1 
 
5.00 g · 100 ml-1 
2.20 g · 100 ml-1 
1.14 g · 100 ml-1 
0.50 g · 100 ml-1 
0.50 g · 100 ml-1 
0.16 g · 100 ml-1 
0.16 g · 100 ml-1 
0.11 g · 100 ml-1 
 
 
1.05 · 10-3 M 
 
1.34 · 10-4 M 
1.36 · 10-4 M 
1.84 · 10-4 M 
4.00 · 10-5 M 
3.29 · 10-4 M 
1.23 · 10-4 M 
1.00 · 10-4 M 
4.44 · 10-6 M 
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2.2.2. Absorbance Measurement 
Algal concentration estimation can be done by direct cell counts, chlorophyll 
content measurement, and absorbance or turbidity numerical correlations (EPA, 
1994). In this study, spectrophotometrical absorbance is the chosen method; 
optical densities were measured at 750 nm. For optical density measurements of 
algae, the wavelength of 750 nm is usually recommended (24, 26, 82). 
Absorbance was measured at 750 nm using Microplate reader (SpectraMax M5). 
250 μl of samples taken at certain days were put into wells of 96 well plate 
triplicates and measured by Microplate reader duplicates.  
2.2.3. HPLC Analysis 
For HPLC analyses, an Inertsil Diol analytical column (150 mm x 4.6 mm, 3 
µm) (GL Sciences, USA) was used at room temperature to separate analytes. 
Acetonitrile and distilled water were used to elute the column at a flow rate of 
0.6 ml/min under a gradient condition. Using gradient method, initial 
acetonitrile ratio was 10% and increased to 60% between 0-18 min and then 
decreased to 10% again between 18-20 min. Total run time was determined as 
25 min. All measurements were performed on Agilent 1200 Series HPLC 
system consisting Agilent 1200 Degasser, 1200 isocratic pump, 1200 ALS auto 
sampler, and 1200 MWD multi wavelength detector monitoring at 254 nm. HP 
Chemstation software was used to analyze and quantify TNT. 
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2.2.4. Acetic Acid Concentration Determination 
Different acetic acid concentrations were used to find out the most effective 
concentration. TAP (Tris-Acetate-Phosphate) medium which is very commonly 
used growth medium for algae was prepared with different acetic acid 
concentrations (1 ml/L, 2 ml/L, 3 ml/L, 4 ml/L and 5 ml/L). All 5 algae were 
grown in these mediums and incubated in dark at 23°C and 170 rpm. OD750 
was measured and growth trend was observed.  
2.2.5. Growth with TNT 
STA1, STA2, STA3, STA4 and STA5 were inoculated in NH4Cl-free-TAP 
medium with TNT. Firstly, the TNT concentrations of 25 mg/L, 50 mg/L and 
100 mg/L were used. Secondly, 3 mg/L, 5 mg/L and 10 mg/L TNT 
concentrations were tested. 1% algae inoculations were done triplicates for each 
sample, incubated in dark at 23°C and 170 rpm for 5 days in first set of 
experiment and for 15 days in the second part. At certain days, samples were 
taken and OD750 was measured and decrease in TNT concentration was 
detected by HPLC analysis. 
2.2.6. Growth in TAP medium with TNT 
STA2, STA3 were inoculated in TAP medium (with NH4Cl) including TNT 
with concentrations of 3 mg/L, 5 mg/L, 10 mg/L and 50 mg/L. 1% algae 
inoculations were done in triplicate for each, incubated in dark at 23°C and 170 
rpm for 7 days. The samples were taken at day 0, 1, 3, 5 and 7 and optical 
density was measured at 750 nm at each day.  
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2.3. RESULTS AND DISCUSSION 
2.3.1. Isolation of Microalgae 
For this study, the algae were examined for their capability of degradation of 
TNT and their survival in the medium containing different amounts of TNT. 
These algae were isolated from water contaminated with TNT (Figure 8) 
obtained from the Brass Factory affiliated with Mechanical and Chemical 
Industry Corporation (MKE) located in Kırıkkale, Turkey. The water 
contaminated with TNT was inoculated on TAP agar and 5 single colonies of 
microalgae were isolated and grown separately. These strains of microalgae 
were called as STA1, STA2, STA3, STA4 and STA5. STA1, STA2 and STA3 
are green colonies while STA4 is red colony and STA5 is orange colony. 
 
Figure 8. Images of water contaminated with TNT obtained from the Brass 
Factory affiliated with Mechanical and Chemical Industry Corporation (MKE) 
located in Kırıkkale, Turkey 
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2.3.2. Acetic Acid Concentration Determination 
TNT is a substance that crystallizes when exposure to light, therefore algae 
should be incubated in dark with TNT to observe the TNT degradation of algae. 
Acetic acid which is the carbon source for algae is an important factor for the 
ability to grow in dark. Therefore, STA2, STA3, STA1, STA4 and STA5 were 
grown in medium with 1 ml/L, 2 ml/L, 3 ml/L, 4 ml/L and 5 ml/L acetic acid 
concentrations and absorbance was measured at 750 nm (Figure 9). As can be 
seen from the Figure 9, no growth was observed for the concentrations of 2 
ml/L, 3 ml/L, 4 ml/L and 5 ml/L. However, for 1 ml/L acetic acid concentration 
there is a significant increase in absorbance values that means the most 
appropriate concentration of acetic acid for the growth of algae was 1 ml/L. 
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Figure 9. Graphs (a), (b), (c), (d) snd (e) show the growth trend of STA1, STA2, 
STA3, STA4 and STA5 respectively in TAP medium with different acetic acid 
concentrations 
STA4 
STA5 
55 
 
In a standard TAP medium, acetic acid concentration is 1 ml/L for normal 
growth of algae.  Therefore, it is considered that less acetic acid concentration 
will not be sufficient in the case of stress of dark and TNT and higher 
concentrations of acetic acid were analyzed. Even algae use acetic acid as 
carbon source, higher amount of this component causes high acidity and inhibit 
the growth.    
2.3.3. Growth with TNT 
For the TNT concentrations of 25 mg/L, 50 mg/L and 100 mg/L the absorbance 
graphs and HPLC results are shown in Figure 10 and Figure 11. 
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Figure 10. Graphs of (a), (b), (c), (d) and (e) represent the absorbance curves of 
STA1, STA2, STA3, STA4 and STA5 for nitrogen free medium, TAP medium 
and 25 mg/L, 50 mg/L and 100 mg/L TNT concentrations respectively 
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According to the absorbance curves (Figure 10), STA1, STA2, STA3 and STA5 
were grown from first day in TAP medium which is a positive control although 
STA4 started to grow later. None of the algae cultures were able to grow at 25 
mg/L, 50 mg/L and 100 mg/L TNT concentrations. It can be concluded that 
STA1, STA2, STA3, STA4 and STA5 do not have enzymes used for TNT 
degradation or the enzymes do not work at that TNT concentrations.  
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Figure 11. The bars of (a), (b), (c), (d) and (e) represent the medium TNT 
concentrations for STA1, STA2, STA3, STA4 and STA5 respectively     
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HPLC results verify the absorbance measurement results. The microalgae did 
not grow in medium with TNT and concentration of TNT did not decrease 
according to HPLC results (Figure 11). 
The TNT concentrations of 25 mg/L, 50 mg/L and 100 mg/L were tested and it 
was concluded that they are high as the microalgae could not grow and could not 
degrade TNT. Therefore, lower concentrations (3 mg/L, 5 mg/L and 10 mg/L) of 
TNT were used to prepare medium. Absorbance measurement curves and HPLC 
results are shown in Figure 12 and Figure 13.  
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Figure 12. Graphs of (a), (b), (c), (d) and (e) represent the absorbance curves of 
STA1, STA2, STA3, STA4 and STA5 for TAP medium and 3 mg/L, 5 mg/L 
and 10 mg/L TNT concentrations respectively. 
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According to Figure 12, for STA1, STA2 and STA3 there is slight growth while 
for STA4 and STA5 even at lower TNT concentrations there is no growth. 
STA4 and STA5 may not use TNT for growth but may utilize TNT for other 
metabolism activities; therefore, HPLC measurements were performed also for 
these concentrations.  
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Figure 13. The bars of (a), (b), (c), (d) and (e) represent the medium TNT 
concentrations for STA1, STA2, STA3, STA4 and STA5 respectively.     
STA5 
STA4 
67 
 
Although there is no growth of STA4 and STA5 in mediums with 3 mg/L TNT, 
5 mg/L TNT and 10 mg/L TNT, Figure 13 shows a decrease of concentration of 
TNT in medium. For STA2, BDS2 and STA1 there is decrease also but at 9. day 
TNT concentrations in medium of STA3 and STA1 increase again. That might 
be occurred because of some experimental errors. As a conclusion, although the 
algae cannot use TNT for growth, they utilize it at different degrees.  
Moreover, as Figure 12 and Figure 13 were interpreted together, for further 
investigation STA2 and STA3 were chosen as they show both slight increase in 
absorbance curves of mediums with TNT and decrease in TNT concentration. 
They did not grow at efficiently high rates but toxicity effect of TNT was low, 
therefore it was investigated if they could survive or grow in the environment of 
TNT with another nitrogen source.  
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Figure 14. Graphs (a) and (b) represent the absorbance curves of STA2 and 
STA3 respectively for nitrogen free medium, TAP medium and TAP medium 
with 3 mg/L, 5 mg/L, 10 mg/L and 50mg/L TNT concentrations. 
Figure 14 shows the growth of STA2 and STA3 in TAP medium (with nitrogen 
source, NH4Cl) with different TNT concentrations (3 mg TNT/L, 5 mg TNT/L, 
10 mg TNT/L and 50 mg TNT/L). STA3 started to grow at 5. day in medium 
with 3 mg TNT/L and cannot grow in mediums with other concentrations of 
TNT tested. However, STA2 grows in the presence of NH4Cl at all TNT 
concentrations tested, even at 50 mg TNT/L concentration of TNT (with a delay 
in growth). This shows that STA2 can survive and grow in the presence of TNT 
(for tested concentrations), although the growth rate is lower than the one in 
TAP medium. The tolerance of STA2 is better than the other algae investigated 
in previous studies in literature as they are inhibited by TNT at concentrations 
between 2 and 15 mg/L (58, 99, 106). 
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2.4.  CONCLUSION 
The goal of this part of the study was to investigate the algae for their capability 
of degradation of TNT and their survival in the medium containing different 
amounts of TNT. These algae were isolated from water contaminated with TNT 
obtained from the Brass Factory affiliated with Mechanical and Chemical 
Industry Corporation (MKE) located in Kırıkkale, Turkey.  Firstly, high 
concentrations (25 mg/L, 50 mg/L and 100 mg/L) of TNT were tested, growth 
and TNT degradation was not observed for five algae samples (STA1, STA2, 
STA3, STA4 and STA5) and TNT concentrations were decreased to 3 mg/L, 5 
mg/L and 10 mg/L. Although the algae tested did not grow well in these media, 
they degraded TNT to some degree. Therefore, the isolated algae cannot use 
TNT as nitrogen source for growth but they utilize it for other metabolic 
activities and can survive in TNT environment so they can be used as biosensors 
in detection of TNT. 
Moreover, STA2 and STA3 were further investigated in terms of toxicity of 
TNT and they were grown in TAP medium (with nitrogen source NH4Cl) 
containing TNT. The previous research indicates the inhibition concentrations of 
TNT for algae as between 2 and 15 mg/L (58, 99, 106). It is shown in this study 
that no inhibition of growth was observed even at 50 mg/L TNT concentration 
for STA2 although its lag phase was longer than the one grown in TAP medium.  
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2.5. FUTURE PROSPECTS 
As a result of the study, growth of STA2 was not inhibited by TNT 
concentrations up to 50 mg/L; therefore, it has the potential to be used in 
biosensor applications for TNT detection. However, more detailed examination 
of STA2 is needed for the biosensor purposes in terms of labeling. Moreover, 
survival mechanism may be further investigated.  
In addition, as a further study, more pink water or TNT contaminated water 
samples may be obtained from different factories and high numbers of 
microalgae can be isolated and tested. By genetic modifications, the survival or 
growth of the microalgae can be improved for both cleaning and biosensor 
purposes. Furthermore, growth conditions of the isolates may be optimized and 
efficiency can be increased for growth rate and survival of algae or degradation 
degree of TNT.    
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